TUMOR-GROWTH INVIVO SELECTS FOR RESISTANCE TO TUMOR NECROSIS FACTOR

被引:0
作者
LATTIME, EC [1 ]
STUTMAN, O [1 ]
机构
[1] MEM SLOAN KETTERING CANC CTR,NEW YORK,NY 10021
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:4317 / 4323
页数:7
相关论文
共 41 条
[1]  
Ausubel F.M., 1992, CURRENT PROTOCOLS MO
[2]   CACHECTIN AND TUMOR-NECROSIS-FACTOR AS 2 SIDES OF THE SAME BIOLOGICAL COIN [J].
BEUTLER, B ;
CERAMI, A .
NATURE, 1986, 320 (6063) :584-588
[3]  
BYKOWSKY MJ, 1986, J IMMUNOL, V137, P1120
[4]   IDENTIFICATION OF A COMMON NUCLEOTIDE-SEQUENCE IN THE 3'-UNTRANSLATED REGION OF MESSENGER-RNA MOLECULES SPECIFYING INFLAMMATORY MEDIATORS [J].
CAPUT, D ;
BEUTLER, B ;
HARTOG, K ;
THAYER, R ;
BROWNSHIMER, S ;
CERAMI, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (06) :1670-1674
[5]   ENDOTOXIN-INDUCED SERUM FACTOR THAT CAUSES NECROSIS OF TUMORS [J].
CARSWELL, EA ;
OLD, LJ ;
KASSEL, RL ;
GREEN, S ;
FIORE, N ;
WILLIAMSON, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1975, 72 (09) :3666-3670
[6]  
CERAMI A, 1986, S QUANT BIOL, V51, P1
[7]  
CONKLING PR, 1988, CANCER RES, V48, P5604
[8]  
FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266
[9]   A PHASE-I TRIAL OF INTRAVENOUSLY-ADMINISTERED RECOMBINANT TUMOR NECROSIS FACTOR-ALPHA IN CANCER-PATIENTS [J].
FEINBERG, B ;
KURZROCK, R ;
TALPAZ, M ;
BLICK, M ;
SAKS, S ;
GUTTERMAN, JU .
JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (08) :1328-1334
[10]  
FEINMAN R, 1987, J IMMUNOL, V138, P635